Effect of the plasma substitutes Gelofusine and Hydroxyethyl Starch 130/0.4 combined with lactated ringer's solution on the coagulation system
Phase 4
Completed
- Conditions
- stollingssysteem na gebruik van de hartlongmachine bij open-hart chirurgiecoagulationplasma substitutestromboelastometry
- Registration Number
- NL-OMON36390
- Lead Sponsor
- Amphia Ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
elective coronary artery bypass grafts procedures
age 18-85 year
Hb > 8.4 mmol/l
Exclusion Criteria
Acute patiënts
Redo operation
Coagulation disorder
Kidney failure
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The thorax drain production after a CABG procedure will be examined after after<br /><br>1, 3, 6, 12 hours on the intensive care. Also the total thorax drain will be<br /><br>examined on the intensive care</p><br>
- Secondary Outcome Measures
Name Time Method